ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1306

Outcome of Lupus Nephritis in Children Less Than 12 Years Old from North-India

Anju Gupta, Bonnie Abujam, Deepti Suri, Amit Rawat and Surjit Singh, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: lupus nephritis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)

Session Type: Abstract Submissions (ACR)

Background/Purpose

 Studies on lupus nephritis in young children below 12 years of age from developing countries are limited. This study looks at long-term outcome in North-Indian children.

Methods

This was a single-center retrospective study from a University referral hospital that provides subsidized treatment. Children seen in the center during the last 25 years were included if they had been diagnosed with systemic lupus erythematosus (as per the ACR 1997 criteria) and lupus nephritis (proteinuria >500mg/day or hematuria (>5RBC/HPF) or any cellular cast) before their 12thbirthday. Initial presentation, laboratory data and treatment received was obtained from the file. Renal biopsy data was classified as per the WHO classification. The primary endpoint was survival with functioning kidneys (absence of death or ESRD). Patients were followed up till January 2012. Kaplan-Meier analysis was used for survival and log-rank test was used to compare different classes. 

Definitions used:Chronic kidney disease = elevated serum creatinine (>1.5mg/dl) for atleast 3 months. End-stage renal disease = need for renal replacement therapy > 3 months.

Results

 This study included 72 children (F: M 3.2:1). The mean± SD age at onset of lupus was 9.3±2.4 years and the duration of disease before presentation was 9.2±12.6 months. Majority of the children (76%) had nephritis at presentation. Renal biopsy was done in 54 children. The histological class was class II in 9, class III in 1, class IV in 35 and class V in 7.    Biopsy was not done in the remaining 18 patients due to poor general condition in 7, ongoing anticoagulation in 5, thrombocytopenia, uncontrolled hypertension and refusal by caregivers in 2 children each. The most common induction treatment was monthy pulses of cyclophosphamide  (6-12 pulses) followed by maintenance with azathioprine or quarterly pulses of cyclophosphamide. At 1 year of follow up, 11 (15%) children had died (all in 1st admission), 11 (15%) were lost to follow up, 36 (50%) were in complete remission and 5 each (6.9%) were in partial remission and active disease. Data for 4 children at 1 year could not be retrieved. Another 11 (15%) children died after the 1st year. The common causes of mortality was infection, disease activity and renal failure. (Table 1).  The mean duration of follow up was 4 ± 4.4 years (0.2-20 years) with a total follow up of 287 patient years. Survival with functioning kidneys was seen in 71% at 3 years, 68% at 5 years and 60% at 10 years. There was no difference in survival among  various histological classes.  

Conclusion   We found a majority of young children presented with lupus nephritis. There was a high mortality at initial presentation. The long term outcome is still much lower as compared to those from the developed nations. Majority of  deaths occur in the initial presentation due to infections, severe disease activity and renal failure. 

Table 1: Causes of death

 

Total

Initial visit

Later

Septicemia

7

7

0

Severe disease activity

3

3

–

End stage renal disease

4

–

4

Disseminated kochs with shunt malfunction

2

–

2

Pulmonary thromboembolism

2

–

2

Hypertensive Intracranial bleed

1

–

1

Myocarditis with left ventricular failure

1

1

–

Unknown cause (died at home)

2

–

2

Total

22(30)

11

11


Disclosure:

A. Gupta,
None;

B. Abujam,
None;

D. Suri,
None;

A. Rawat,
None;

S. Singh,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcome-of-lupus-nephritis-in-children-less-than-12-years-old-from-north-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology